Literature DB >> 3263424

Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease.

J P Portanova1, F M Ebling, W S Hammond, B H Hahn, B L Kotzin.   

Abstract

A graft-vs-host (GVH) reaction of parental T cells in allogeneic F1 mice can lead to an autoimmune disease resembling human SLE. We analyzed the contribution of MHC genes to the development of IgG antinuclear antibody production and immune complex glomerulonephritis in MHC-congenic F1 recipients. DBA/2 T cells elicited IgG antibodies to histone, ssDNA, and dsDNA in all histoincompatible F1 recipients that were studied. The anti-DNA antibody responses were quantitatively similar among the F1 combinations and displayed comparable IgG2a subclass and cationic charge characteristics. In contrast, severe renal disease was manifested only in F1 mice that expressed H-2b encoded class II gene products. Disease susceptibility was associated with a decrease in circulating anti-DNA antibodies and a characteristic localization of immune complexes in the glomeruli. The data suggest that the production of potentially pathogenic IgG anti-nuclear antibodies is not sufficient for the development of renal disease in GVH-induced lupus. Thus, another event separate from autoantibody production is MHC dependent and appears to be critical for the formation and/or deposition of pathologic immune complexes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263424

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.

Authors:  K Nagaraju; N Raben; L Loeffler; T Parker; P J Rochon; E Lee; C Danning; R Wada; C Thompson; G Bahtiyar; J Craft; R Hooft Van Huijsduijnen; P Plotz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.

Authors:  Anthony D Foster; Mark Haas; Irina Puliaeva; Kateryna Soloviova; Roman Puliaev; Charles S Via
Journal:  Clin Immunol       Date:  2010-05-06       Impact factor: 3.969

Review 3.  Microchimerism and HLA relationships of pregnancy: implications for autoimmune diseases.

Authors:  J L Nelson
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 4.  Advances in lupus stemming from the parent-into-F1 model.

Authors:  Charles S Via
Journal:  Trends Immunol       Date:  2010-03-31       Impact factor: 16.687

5.  Microchimerism of maternal origin persists into adult life.

Authors:  S Maloney; A Smith; D E Furst; D Myerson; K Rupert; P C Evans; J L Nelson
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

6.  Pre-clinical screening of immunomodulatory compounds using the parent-into-F1 model.

Authors:  Charles S Via
Journal:  Clin Immunol       Date:  2011-06-12       Impact factor: 3.969

Review 7.  T cells, murine chronic graft-versus-host disease and autoimmunity.

Authors:  Robert A Eisenberg; Charles S Via
Journal:  J Autoimmun       Date:  2012-06-16       Impact factor: 7.094

8.  Hyper IgE in stimulatory graft-versus-host disease: role of interleukin-4.

Authors:  J M Doutrelepont; M Moser; O Leo; D Abramowicz; M L Vanderhaegen; J Urbain; M Goldman
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

Review 9.  New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation.

Authors:  Y Shoenfeld; I Krause; M Blank
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

10.  Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Clifton L Dalgard; Brian C Schaefer; Charles S Via
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.